Incyte Corporation
INCY | NASDAQ
$125.69
+$0.38 (+0.30%)
Sep 21, 2026, 12:49 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 5.14B | 4.24B | 3.7B | 3.39B | 2.99B | 2.67B |
Cost of Revenue | 372.1M | 312.1M | 254.99M | 207M | 150.99M | 131.3M |
Gross Profit | 4.77B | 3.93B | 3.44B | 3.19B | 2.84B | 2.54B |
Operating Income | 1.34B | 101.29M | 655.36M | 591.63M | 585.78M | -263.68M |
Interest Income | 105.6M | 128.71M | n/a | n/a | n/a | n/a |
Pretax Income | 1.66B | 316.63M | 834.22M | 529.12M | 570.44M | -232.22M |
Net Income | 1.29B | 32.62M | 597.6M | 340.66M | 948.58M | -295.7M |
Selling & General & Admin | 1.38B | 1.22B | 1.16B | 1B | 739.56M | 516.9M |
Research & Development | 2.05B | 2.61B | 1.63B | 1.59B | 1.46B | 2.22B |
Other Expenses | n/a | -1.03M | 2.05M | 7.97M | 51.76M | 66.24M |
Operating Expenses | 3.43B | 3.83B | 2.79B | 2.6B | 2.25B | 2.8B |
Interest Expense | 2.43M | 2.28M | 2.55M | 2.67M | 1.91M | 2.17M |
Selling & Marketing Expenses | n/a | n/a | -5.64M | n/a | -40K | n/a |
Cost & Expenses | 3.8B | 4.14B | 3.04B | 2.8B | 2.4B | 2.93B |
Income Tax Expense | 377.8M | 284.02M | 236.62M | 188.46M | -378.14M | 63.48M |
Shares Outstanding (Basic) | 195.2M | 207.11M | 223.63M | 222M | 220.43M | 218.07M |
Shares Outstanding (Diluted) | 200.7M | 210.53M | 225.93M | 223.96M | 222.07M | 218.07M |
EPS (Basic) | 6.59 | 0.16 | 2.67 | 1.53 | 4.30 | -1.36 |
EPS (Diluted) | 6.41 | 0.15 | 2.65 | 1.52 | 4.27 | -1.36 |
EBITDA | 1.76B | 408.16M | 919.43M | 599.64M | 630.2M | -178.24M |
EBIT | 1.67B | 318.91M | 836.77M | 531.78M | 572.35M | -230.04M |
Depreciation & Amortization | 93.29M | 89.25M | 82.66M | 67.86M | 57.84M | 51.81M |
Add to Watchlist
Select watchlists to add or remove INCY